<SEC-DOCUMENT>0001193125-25-305250-index.html : 20251202 <SEC-HEADER>0001193125-25-305250.hdr.sgml : 20251202 <ACCEPTANCE-DATETIME>20251202160539 ACCESSION NUMBER: 0001193125-25-305250 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 6 CONFORMED PERIOD OF REPORT: 20251202 FILED AS OF DATE: 20251202 DATE AS OF CHANGE: 20251202 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KAZIA THERAPEUTICS LTD CENTRAL INDEX KEY: 0001075880 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: C3 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-29962 FILM NUMBER: 251543159 BUSINESS ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: THREE INTERNATIONAL TOWERS LEVEL 24, STREET 2: 300 BARANGAROO AVENUE CITY: SYDNEY NSW PROVINCE COUNTRY: C3 ZIP: 2000 BUSINESS PHONE: 01161298780088 MAIL ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: THREE INTERNATIONAL TOWERS LEVEL 24, STREET 2: 300 BARANGAROO AVENUE CITY: SYDNEY NSW PROVINCE COUNTRY: C3 ZIP: 2000 FORMER COMPANY: FORMER CONFORMED NAME: NOVOGEN LTD DATE OF NAME CHANGE: 19981228 </SEC-HEADER> <DOCUMENT> <TYPE>6-K <SEQUENCE>1 <FILENAME>d15328d6k.htm <DESCRIPTION>6-K <TEXT> Document 1 - file: d15328d6k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.1 <SEQUENCE>2 <FILENAME>d15328dex41.htm <DESCRIPTION>EX-4.1 <TEXT> Document 2 - file: d15328dex41.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.2 <SEQUENCE>3 <FILENAME>d15328dex42.htm <DESCRIPTION>EX-4.2 <TEXT> Document 3 - file: d15328dex42.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.1 <SEQUENCE>4 <FILENAME>d15328dex101.htm <DESCRIPTION>EX-10.1 <TEXT> Document 4 - file: d15328dex101.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.2 <SEQUENCE>5 <FILENAME>d15328dex102.htm <DESCRIPTION>EX-10.2 <TEXT> Document 5 - file: d15328dex102.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>6 <FILENAME>d15328dex991.htm <DESCRIPTION>EX-99.1 <TEXT> Document 6 - file: d15328dex991.htm
</DOCUMENT> </SEC-DOCUMENT>